Studies Investigate Whether Antivirals Like Paxlovid May Prevent Long COVID

The US Food and Drug Administration has yet to approve any drugs for preventing or treating post–COVID-19 condition, also known as long COVID—defined by the US government as health issues that continue or develop 4 weeks or more after an initial SARS-CoV-2 infection. But 2 recent observational studies took a close look at whether existing antiviral treatments for COVID-19 may protect against developing long COVID down the line.